Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: GlobalData | PRODUCT CODE: 1553869

Cover Image

PUBLISHER: GlobalData | PRODUCT CODE: 1553869

North America Cardiovascular Surgery Devices Market Outlook to 2033 - Beating Heart Surgery Systems and Perfusion Disposables

PUBLISHED:
PAGES: 93 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 5995
PDF (Site License)
USD 11990
PDF (Global License)
USD 17985

Add to Cart

GlobalData's "North America Cardiovascular Surgery Devices Market Outlook to 2033" is a comprehensive databook report, covering key market data on the North America Cardiovascular Surgery Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Beating Heart Surgery Systems and Perfusion Disposables

The North America Cardiovascular Surgery Devices Market report provides key information and data on -

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2023 company share and distribution share data for Cardiovascular Surgery Devices Market.
  • Global corporate-level profiles of key companies operating within the North America Cardiovascular Surgery Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

North America Cardiovascular Surgery Devices is segmented as follows -

  • Beating Heart Surgery Systems
  • Perfusion Disposables

Reasons to Buy

The North America Cardiovascular Surgery Devices Market report helps you to develop -

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Understand the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
Product Code: GDME0386CRDB

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 What Is This Report About?
  • 2.2 Cardiovascular Surgery Devices Segmentation
  • 2.3 Definitions of Markets Covered in the Report

3 Cardiovascular Surgery Devices Market, North America

  • 3.1 Cardiovascular Surgery Devices Market, North America, Revenue ($m), 2018-2033
  • 3.2 Cardiovascular Surgery Devices Market, North America, Revenue ($m), 2018-2033
  • 3.3 Cardiovascular Surgery Devices Market, North America, Volume (Units), 2018-2033
  • 3.4 Cardiovascular Surgery Devices Market, North America, Volume (Units), 2018-2033
  • 3.5 Cardiovascular Surgery Devices Market, North America, Company Share by Revenue ($m), 2023

4 Cardiovascular Surgery Devices Market, Canada

  • 4.1 Cardiovascular Surgery Devices Market, Canada, Revenue ($m), 2018-2033
    • 4.1.1 Beating Heart Surgery Systems Market, Canada, Revenue ($m), by Segment, 2018-2033
    • 4.1.2 Perfusion Disposables Market, Canada, Revenue ($m), by Segment, 2018-2033
  • 4.2 Cardiovascular Surgery Devices Market, Canada, Volume (Units), 2018-2033
    • 4.2.1 Beating Heart Surgery Systems Market, Canada, Volume (Units), by Segment, 2018-2033
    • 4.2.2 Perfusion Disposables Market, Canada, Volume (Units), by Segment, 2018-2033
  • 4.3 Cardiovascular Surgery Devices Market, Canada, Average Price ($), 2018-2033
  • 4.4 Cardiovascular Surgery Devices Market, Canada, Distribution Share by Revenue ($m), 2023
  • 4.5 Cardiovascular Surgery Devices Market, Canada, Company Share by Revenue ($m), 2023

5 Cardiovascular Surgery Devices Market, Mexico

  • 5.1 Cardiovascular Surgery Devices Market, Mexico, Revenue ($m), 2018-2033
    • 5.1.1 Beating Heart Surgery Systems Market, Mexico, Revenue ($m), by Segment, 2018-2033
    • 5.1.2 Perfusion Disposables Market, Mexico, Revenue ($m), by Segment, 2018-2033
  • 5.2 Cardiovascular Surgery Devices Market, Mexico, Volume (Units), 2018-2033
    • 5.2.1 Beating Heart Surgery Systems Market, Mexico, Volume (Units), by Segment, 2018-2033
    • 5.2.2 Perfusion Disposables Market, Mexico, Volume (Units), by Segment, 2018-2033
  • 5.3 Cardiovascular Surgery Devices Market, Mexico, Average Price ($), 2018-2033
  • 5.4 Cardiovascular Surgery Devices Market, Mexico, Distribution Share by Revenue ($m), 2023
  • 5.5 Cardiovascular Surgery Devices Market, Mexico, Company Share by Revenue ($m), 2023

6 Cardiovascular Surgery Devices Market, United States

  • 6.1 Cardiovascular Surgery Devices Market, United States, Revenue ($m), 2018-2033
    • 6.1.1 Beating Heart Surgery Systems Market, United States, Revenue ($m), by Segment, 2018-2033
    • 6.1.2 Perfusion Disposables Market, United States, Revenue ($m), by Segment, 2018-2033
  • 6.2 Cardiovascular Surgery Devices Market, United States, Volume (Units), 2018-2033
    • 6.2.1 Beating Heart Surgery Systems Market, United States, Volume (Units), by Segment, 2018-2033
    • 6.2.2 Perfusion Disposables Market, United States, Volume (Units), by Segment, 2018-2033
  • 6.3 Cardiovascular Surgery Devices Market, United States, Average Price ($), 2018-2033
  • 6.4 Cardiovascular Surgery Devices Market, United States, Distribution Share by Revenue ($m), 2023
  • 6.5 Cardiovascular Surgery Devices Market, United States, Company Share by Revenue ($m), 2023

7 Overview of Key Companies in North America Cardiovascular Surgery Devices Market

  • 7.1 Getinge AB
    • 7.1.1 Company Overview
  • 7.2 Abbott Laboratories
    • 7.2.1 Company Overview
  • 7.3 Medtronic Plc
    • 7.3.1 Company Overview
  • 7.4 Terumo Corp
    • 7.4.1 Company Overview
  • 7.5 Fresenius SE & Co KGaA
    • 7.5.1 Company Overview
  • 7.6 LivaNova Plc
    • 7.6.1 Company Overview
  • 7.7 Edwards Lifesciences Corp
    • 7.7.1 Company Overview
  • 7.8 Abiomed Inc
    • 7.8.1 Company Overview
  • 7.9 Braile Biomedica Ltda
    • 7.9.1 Company Overview
  • 7.10 Nipro Corp
    • 7.10.1 Company Overview
  • 7.11 Eurosets Srl
    • 7.11.1 Company Overview

8 Cardiovascular Surgery Devices Market Pipeline Products

9 Recent Developments

  • 9.1 Corporate Communications
    • 9.1.1 Jun 26, 2024: MIMEDX Announces the Appointment of Kim Moller to Chief Commercial Officer
    • 9.1.2 Feb 28, 2024: Integra LifeSciences Announces Leadership Transition Plan
    • 9.1.3 Jan 11, 2024: James Kostek, DO Named New Medical Director of Babs Siperstein PROUD Center
    • 9.1.4 Dec 18, 2023: Merit Medical Announces Process for Chief Executive Officer Succession Planning
    • 9.1.5 Oct 13, 2023: Elos Medtech Notice to Attend the Extraordinary General Meeting
    • 9.1.6 Oct 04, 2023: Boston University Names Melissa L. Gilliam 11th President
  • 9.2 Financial Announcements
    • 9.2.1 Jun 18, 2024: Merit Medical Systems to Announce Second Quarter 2024 Results on August 1, 2024
    • 9.2.2 Apr 25, 2024: Edwards Lifesciences Reports First Quarter Results
    • 9.2.3 Feb 28, 2024: Merit Medical Introduces 'Continued Growth Initiatives' Program and Financial Targets for Three-Year Period Ending December 31, 2026
    • 9.2.4 Jan 16, 2024: Surmodics to Report First Quarter of Fiscal 2024 Financial Results on February 1
    • 9.2.5 Jan 05, 2024: Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results
    • 9.2.6 Oct 26, 2023: Boston Scientific Announces Results for Third Quarter 2023
    • 9.2.7 Oct 19, 2023: Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2023 Financial Results
    • 9.2.8 Oct 18, 2023: Edwards Lifesciences to Host Earnings Conference Call on October 25, 2023
    • 9.2.9 Oct 16, 2023: MIMEDX to Host Third Quarter 2023 Operating and Financial Results Conference Call on October 30
  • 9.3 Government and Public Interest
    • 9.3.1 Jun 01, 2024: Typhoid Fever Vaccine "Tyfim V-I Injection Syringe" Information Regarding Obtaining Manufacturing and Sales Approval
    • 9.3.2 Feb 23, 2024: Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
    • 9.3.3 Nov 08, 2023: MediWound Announces a Collaboration with PolyMedics Innovations (PMI) for NexoBrid Distribution in Europe
    • 9.3.4 Aug 29, 2023: SI-BONE To Present at Morgan Stanley 21st Annual Global Healthcare Conference on September 12, 2023
    • 9.3.5 Aug 28, 2023: Edwards Lifesciences to Present at the 2023 Wells Fargo Healthcare Conference
    • 9.3.6 Aug 11, 2023: W. L. Gore & Associates to Present New Mosa Paper At Gvsets Conference

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Coverage
    • 10.1.2 Secondary Research
    • 10.1.3 Primary Research
    • 10.1.4 Market Modeling and Forecasting
    • 10.1.5 Company Share Analysis
    • 10.1.6 Distribution Share Analysis
    • 10.1.7 Benchmarking
  • 10.2 GlobalData Consulting
  • 10.3 Contact Us
  • 10.4 Disclaimer
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!